Fatigue News and Research

RSS

Adding MM-398 to standard treatment improves survival in metastatic pancreatic cancer patients

Adding the novel MM-398 to standard treatment for metastatic pancreatic cancer patients who have already received gemcitabine improves survival, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona.

26 Jun 2014

Intercalated erlotinib–eribulin ‘feasible’ without added efficacy

Erlotinib can be intercalated with the anti-tubule agent eribulin mesylate for patients with advanced non-small-cell lung cancer but it is unlikely to increase treatment efficacy in those without epidermal growth factor receptor activating mutations, research suggests.

25 Jun 2014

Required dose of saline solutions can prevent common injuries in football players

Some of the most common injuries in football players are violent joint sprains and muscle strains in the legs, which are sometimes caused by anxiety and fatigue accumulated after several games in a few weeks.

25 Jun 2014

Patients with Cushing’s syndrome experience significant weight loss while taking oral medication

Sinai Hospital of Baltimore endocrinologist, Henry G. Fein, M.D., today presented new research showing that patients with Cushing's syndrome, a rare disease that can lead to extreme weight gain, type 2 diabetes, high blood pressure and psychological issues, experienced significant, sustained weight loss while taking oral medication daily over a number of years to manage symptoms of the disease.

25 Jun 2014

Testosterone therapy may improve aerobic capacity in aging men

Testosterone replacement therapy may help older men who have limited mobility and low testosterone improve their aerobic capacity and lessen its decline with age, new research finds.

24 Jun 2014

Osteoarthritis may be treated with stem cell mobilization therapy

Researchers in Taiwan have found that peripheral blood stem cells can be "mobilized" by injection of a special preparation of granulocyte colony-stimulating factor (G-CSF) into rats that modeled osteoarthritis (OA).

20 Jun 2014

Yoga exercise program developed for patients living with pulmonary hypertension

A first-of-its-kind yoga exercise program has been developed by Henry Ford Hospital for patients living with pulmonary hypertension, a chronic lung disease that afflicts women at least two times more than men.

19 Jun 2014

Survival differences after docetaxel, erlotinib are EGFR dependent

Results from the DELTA trial indicate no significant differences in progression-free or overall survival after treatment with docetaxel versus erlotinib in non-small-cell lung cancer patients unselected for their epidermal growth factor receptor mutation status.

16 Jun 2014

New survey explores impact of chronic fatigue on people with rheumatoid arthritis

The National Rheumatoid Arthritis Society in collaboration with 2020health, a leading health social enterprise think tank, today announces the results from Invisible Disease: RA and Chronic Fatigue 2014, a survey of 1,954 people with Rheumatoid Arthritis (RA), to assess the impact of chronic fatigue on their capability for work, emotional and mental health as well as the overall experience of chronic fatigue caused by their RA.

16 Jun 2014

Viewpoints: VA fix comes with big pricetag; safety outside abortion clinics; questions about Medicaid eligibility

As an example of how the normally sclerotic Congress can act extremely quickly when properly motivated, both chambers passed bills this week to ameliorate the Veterans Affairs health services scandal.

16 Jun 2014

Dancing eases hip or knee pain and helps older adults move better

Dancing eases hip or knee pain and helps older adults move better, according to a small Saint Louis University study.

13 Jun 2014

Ohio State doctors treat heart failure patients with new wireless, implantable hemodynamic monitor

Doctors at The Ohio State University Wexner Medical Center are the first in the country to begin treating some heart failure patients with a new wireless, implantable hemodynamic monitor that was just approved by the U.S. Food and Drug Administration. The monitor will help physicians observe pulmonary artery pressures, optimize treatment and prevent hospitalizations.

10 Jun 2014

FDA accepts Pharmacyclics' IMBRUVICA sNDA for review

Pharmacyclics, Inc. today announced that the U.S. Food and Drug Administration has accepted for filing its supplemental New Drug Application (sNDA) to support the review of IMBRUVICA (ibrutinib) in the treatment of patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) who have received at least one prior therapy for a full approval.

9 Jun 2014

BioDelivery Sciences receives approval of NDA for BUNAVAIL from FDA

BioDelivery Sciences International, Inc. received approval of the New Drug Application (NDA) for BUNAVAIL™ (buprenorphine and naloxone) buccal film (CIII) from the U.S. Food and Drug Administration (FDA).

9 Jun 2014

About MS booklet now available as a printed and online publication

The Multiple Sclerosis Association of America is pleased to announce that the newly published About MS booklet is now available as both a printed and online publication.

6 Jun 2014

Utz Quality Foods donates $2 million toward breast cancer survivorship program

Utz Quality Foods Inc., Executive Chairman Michael Rice and his wife Jane, a breast cancer survivor, have donated $2 million toward a breast cancer survivorship program at the Johns Hopkins Kimmel Cancer Center.

6 Jun 2014

Merck enrolls first patient in reformulated raltegravir Phase 3 trial for treatment of HIV-1 infection

Merck, known as MSD outside the United States and Canada, today announced that the first patient has been enrolled in the company's global Phase 3 clinical trial, ONCEMRK.

6 Jun 2014

Interim data from Promedior’s PRM-151 Phase 2 myelofibrosis clinical trial to be presented at 19th EHA Congress

Promedior, Inc., a clinical stage biotechnology company developing novel therapeutics for the treatment of fibrosis, today announced that Ruben Mesa, MD, will present interim data from the Company's ongoing Phase 2 clinical trial of its lead product candidate, PRM-151, for the treatment of myelofibrosis, in a poster presentation on June 14, 2014 at the 19th Congress of European Hematology Association (EHA) which is being held in Milan, Italy, from June 12-15, 2014.

5 Jun 2014

Incyte’s ruxolitinib Phase III study for polycythemia vera achieves primary endpoint

Incyte Corporation (Nasdaq: INCY) today announced results from the RESPONSE trial, the first pivotal Phase III study evaluating a JAK1/JAK2 inhibitor for the treatment of polycythemia vera (PV).

4 Jun 2014

Enzalutamide drug proves effective in stemming progression of prostate cancer

A drug used to treat men with late-stage prostate cancer proved effective in stemming progression of the disease in research participants who had not yet received chemotherapy and extended their survival, according to results from a multi-national Phase III clinical trial led by the Knight Cancer Institute at Oregon Health & Science University.

3 Jun 2014

Fatigue News and Research

Adding MM-398 to standard treatment improves survival in metastatic pancreatic cancer patients

Intercalated erlotinib–eribulin ‘feasible’ without added efficacy

Required dose of saline solutions can prevent common injuries in football players

Patients with Cushing’s syndrome experience significant weight loss while taking oral medication

Testosterone therapy may improve aerobic capacity in aging men

Osteoarthritis may be treated with stem cell mobilization therapy

Yoga exercise program developed for patients living with pulmonary hypertension

Survival differences after docetaxel, erlotinib are EGFR dependent

New survey explores impact of chronic fatigue on people with rheumatoid arthritis

Viewpoints: VA fix comes with big pricetag; safety outside abortion clinics; questions about Medicaid eligibility

Dancing eases hip or knee pain and helps older adults move better

Ohio State doctors treat heart failure patients with new wireless, implantable hemodynamic monitor

FDA accepts Pharmacyclics' IMBRUVICA sNDA for review

BioDelivery Sciences receives approval of NDA for BUNAVAIL from FDA

About MS booklet now available as a printed and online publication

Utz Quality Foods donates $2 million toward breast cancer survivorship program

Merck enrolls first patient in reformulated raltegravir Phase 3 trial for treatment of HIV-1 infection

Interim data from Promedior’s PRM-151 Phase 2 myelofibrosis clinical trial to be presented at 19th EHA Congress

Incyte’s ruxolitinib Phase III study for polycythemia vera achieves primary endpoint

Enzalutamide drug proves effective in stemming progression of prostate cancer

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News